Pulse pressure and heart rate in patients with metabolic syndrome across Europe: Insights from the GOOD survey

Journal of Human Hypertension

Volumn 27, Issue 7, 2013, Pages 412-416

  Perlini, S ^a   Naditch Brule, L ^b   Farsang, C ^c   Zidek, W ^d   Kjeldsen, S E ^e  

^a UNIVERSITY OF PAVIA   (Italy)

^b SANOFI   (France)

^c Szent Imre Hospital   (Hungary)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; EUROPE; FEMALE; HEALTH SURVEY; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULSE PRESSURE;

AGED; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HEALTH SURVEYS; HEART RATE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OUTPATIENTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84879414642     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2012.61     Document Type: Article

References (33)

1. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112(6): 736-749. (Pubitemid 11130662)
2. Kannel WB, Kannel C, Paffenbarger Jr RS, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113(6): 1489-1494. (Pubitemid 17092823)
3. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125(4): 1148-1154. (Pubitemid 23117352)
4. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26(10): 967-974. (Pubitemid 40695027)
5. Palatini P. Heart rate: a strong predictor of mortality in subjects with coronary artery disease. Eur Heart J 2005; 26(10): 943-945. (Pubitemid 40695020)
6. Laurent S, Tropeano AI, Boutouyrie P. Pulse pressure reduction and cardiovascular protection. J Hypertens Suppl 2006; 24(3): S13-S18. (Pubitemid 44336814)
7. Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47(1): 72-75. (Pubitemid 43005167)
8. Franklin SS. Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance? Curr Hypertens Rep 2000; 2(3): 253-259.
9. Volpe M, Tocci G, Trimarco B, Agabiti-Rosei E, Borghi C, Ambrosioni E et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25(7): 1491-1498. (Pubitemid 46918838)
10. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007; 167(2): 141-147. (Pubitemid 46151611)
11. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43(1): 10-17. (Pubitemid 38031904)
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-1187. (Pubitemid 46924065)
13. Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens 2008; 26(10): 2064-2070.
14. Zidek W, Naditch-Brule L, Perlini S, Farsang C, Kjeldsen SE. Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovasc Diabetol 2009; 8: 51.
15. Mulè G, Nardi E, Cottone S, Cusimano P, Palermo A, Incalcaterra F et al. Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients. J Cardiometab Syndr 2007; 2(2): 84-90.
16. Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 2007; 20(2): 127-133. (Pubitemid 46150012)
17. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21(6): 1011-1053.
18. Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE. Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens 2009; 23(5): 316-324.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005; 13(6): 322-327.
20. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50(24): 2285-2290. (Pubitemid 350192103)
21. Floras JS. Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure. Ann NY Acad Sci 2001; 940: 500-513. (Pubitemid 32623418)
22. Radaelli A, Castiglioni P, Balestri G, Cesana F, De Carlini C, Soriano F et al. Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure. J Hypertens 2010; 28(9): 1908-1912.
23. Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43(10): 1817-1822. (Pubitemid 38622521)
24. Vazquez Vigoa A, Vazquez Cruz A, Calderin RO, Buchaca EF, Cruz Alvarez NM, Jimenez Paneque R et al. [Metabolic syndrome in patients with essential hypertension]. Nefrologia 2003; 23(5): 423-431. (Pubitemid 39233233)
25. Navarro J, Redon J, Cea-Calvo L, Lozano JV, Fernandez-Perez C, Bonet A et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press 2007; 16(1): 20-27. (Pubitemid 46679444)
26. Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003; 14(2): 101-106. (Pubitemid 36457952)
27. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22(10): 1991-1998. (Pubitemid 39336683)
28. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Parodi A et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 2005; 257(5): 454-460. (Pubitemid 40613071)
29. Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257(6): 503-513. (Pubitemid 40776510)
30. Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 2007; 49(3): 535-541.
31. Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22(2): 151-155.
32. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288(21): 2709-2716. (Pubitemid 35403784)
33. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147(1): 106-112. (Pubitemid 38037405)